Neuropilin-1 is a receptor for transforming growth factor β-1, activates its latent form, and promotes regulatory T cell activity
Open Access
- 24 April 2008
- journal article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 84 (1) , 302-310
- https://doi.org/10.1189/jlb.0208090
Abstract
Neuropilin-1 (Nrp1) is a multifunctional protein, identified principally as a receptor for the class 3 semaphorins and members of the vascular endothelial growth factor (VEGF) family, but it is capable of other interactions. It is a marker of regulatory T cells (Tr), which often carry Nrp1 and latency-associated peptide (LAP)-TGF-β1 (the latent form). The signaling TGF-β1 receptors bind only active TGF-β1, and we hypothesized that Nrp1 binds the latent form. Indeed, we found that Nrp1 is a high-affinity receptor for latent and active TGF-β1. Free LAP, LAP-TGF-β1, and active TGF-β1 all competed with VEGF165 for binding to Nrp1. LAP has a basic, arginine-rich C-terminal motif similar to VEGF and peptides that bind to the b1 domain of Nrp1. A C-terminal LAP peptide (QSSRHRR) bound to Nrp1 and inhibited the binding of VEGF and LAP-TGF-β1. We also analyzed the effects of Nrp1/LAP-TGF-β1 coexpression on T cell function. Compared with Nrp1– cells, sorted Nrp1+ T cells had a much greater capacity to capture LAP-TGF-β1. Sorted Nrp1– T cells captured soluble Nrp1-Fc, and this increased their ability to capture LAP-TGF-β1. Conventional CD4+CD25–Nrp1– T cells coated with Nrp1-Fc/LAP-TGF-β1 acquired strong Tr activity. Moreover, LAP-TGF-β was activated by Nrp1-Fc and also by a peptide of the b2 domain of Nrp1 (RKFK; similar to a thrombospondin-1 peptide). Breast cancer cells, which express Nrp1, also captured and activated LAP-TGF-β1 in a Nrp1-dependent manner. Thus, Nrp1 is a receptor for TGF-β1, activates its latent form, and is relevant to Tr activity and tumor biology.Keywords
Funding Information
- Ontario Institute for Cancer Research
- Province of Ontario
- Juvenile Diabetes Foundation International
- Canadian Diabetes Association
- Krembil Foundation
- Li Ka Shing Knowledge Institute
- Keenan Research Centre of St. Michael’s Hospital
This publication has 36 references indexed in Scilit:
- Neuropilin-1 and neuropilin-2 act as coreceptors, potentiating proangiogenic activityBlood, 2008
- Neuropilin-1 Modulates p53/Caspases Axis to Promote Endothelial Cell SurvivalPLOS ONE, 2007
- Hepatocyte Growth Factor–Mediated Cell Invasion in Pancreatic Cancer Cells Is Dependent on Neuropilin-1Cancer Research, 2007
- Neuropilin-1 interacts with integrin β1 and modulates pancreatic cancer cell growth, survival and invasionCancer Biology & Therapy, 2007
- Vascular endothelial growth factor (VEGF) signaling in tumor progressionCritical Reviews in Oncology/Hematology, 2007
- Neuropilins in physiological and pathological angiogenesisThe Journal of Pathology, 2007
- Structural basis for ligand and heparin binding to neuropilin B domainsProceedings of the National Academy of Sciences, 2007
- Interactions of Multiple Heparin Binding Growth Factors with Neuropilin-1 and Potentiation of the Activity of Fibroblast Growth Factor-2Journal of Biological Chemistry, 2005
- Crystal Structure of the Human Neuropilin-1 b1 DomainStructure, 2003
- Neuropilin-1 Mediates Collapsin-1/Semaphorin III Inhibition of Endothelial Cell MotilityThe Journal of cell biology, 1999